Investor Center
Summit is publicly listed in the US (NASDAQ)


News
Summit Therapeutics Partners with Akeso Inc. in Deal for Up to $5 Billion to In-License Breakthrough Innovative Bispecific Antibody
VIEW NEWS
Summit Therapeutics Appoints Experienced Clinical Leader Dr. Alessandra Cesano to its Board of Directors
VIEW NEWS
Share Price
NASDAQ: SMMT
At 28/01/2023 04:10
SEC Filings
Current report filing
VIEW FILING
Initial statement of beneficial ownership of securities
VIEW FILING
Analyst Coverage
VisitShareholder Meetings
VisitCorporate Governance
The board believes that good corporate governance is integral to a successful business. We look to apply the highest standards of corporate governance appropriate to a company of our size and development stage, while balancing the need to ensure that the business has the correct level of skills and expertise required to manage a global company and fulfil our regulatory obligations into distinct jurisdictions.